Renub Research has published a document titled “Global Viscosupplementation Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2030,” which includes market share statistics and a thorough enterprise analysis. This report concentrates on the Global Viscosupplementation Market’s competition, geographic distribution, and growth capability.
The global Viscosupplementation Market is expected to amplify at a CAGR of 8.96% between 2024 and 2030. Viscosupplementation includes injecting a lubricating fluid, usually hyaluronic acid, into joints to alleviate aches and improve mobility, in most cases in osteoarthritis patients. This minimally invasive method aims to repair joint lubrication, decreasing friction and improving shock absorption. Widely employed in knee joints, viscosupplementation provides a cushioning effect, relieving aches and infections associated with degenerative joint conditions. As a non-surgical opportunity, it offers prolonged comfort, delaying the need for more invasive interventions. With ongoing studies exploring its applications in numerous joints and situations, viscosupplementation continues to conform as a valuing healing alternative for boosting joint functioning and mitigating the effect of degenerative joint illnesses.
The viscosupplementation market is expanding with various applications and technological advancements, extending beyond knee osteoarthritis to include diverse joints like hips and shoulders with the help of progressive formulations. The demand for non-surgical joint management solutions is increasing due to an aging global population. North America and Europe dominate this market due to their higher healthcare spending and focus. Emerging economies in the Asia-Pacific region are proliferating due to an increasing disposable income and a growing elderly population. Ongoing research guarantees the unveiling of new applications, ensuring sustained expansion and addressing a broader range of musculoskeletal demanding situations in the viscosupplementation market. So, the Global Viscosupplementation Market is projected to reach US$ 7.81 Billion by 2030.
Moreover, producers strategically broaden cost-powerful hyaluronic acid options in the dynamic viscosupplementation market and refine injection protocols for broader patient accessibility. Simultaneously, advocacy efforts and proof-based demonstrations drive the rush for favorable reimbursement guidelines, emphasizing viscosupplementation long-term cost-effectiveness. The industry is shifting towards a comprehensive method through exploring combination healing procedures and integrating viscosupplementation with osteoarthritis remedies like physical therapy and pain control. This approach complements patient outcomes and broadens the market appeal of viscosupplementation, organizing it as a versatile and practical solution in osteoarthritis management.
Due to its convenience and patient-friendly approach, the single-injection viscosupplementation section is poised for a future boom.
As healthcare traits evolve, there’s a growing choice of efficient remedy alternatives, and a single injection aligns with this demand. Patients benefit from reduced remedy burden, fewer hospital visits, and stepped-forward adherence. Also, improvements in components and technology enhance the efficacy of single injections, resulting in positive patient outcomes. This streamlined technique resonates with healthcare carriers searching for time-efficient solutions, contributing to the predicted increase of single-injection viscosupplementation in the future healthcare panorama.
Product – Global Viscosupplementation Market breakup from 3 viewpoints:
- Single Injection Viscosupplementation
- Three Injections Viscosupplementation
- Five Injections Viscosupplementation
Knee osteoarthritis has emerged due to its high occurrence and the increasing aging population due to the dominant force in the viscosupplementation market.
With a growing number of individuals experiencing knee osteoarthritis-related pain and limitations, there’s a heightened demand for effective and minimally invasive treatments. Viscosupplementation, especially in knee joints, presents a targeted and efficient solution, imparting a remedy for aches and enhancing joint features. The process’s success in managing knee osteoarthritis symptoms has hooked it up as a desired preference amongst healthcare practitioners and patients, consolidating its prominence and market dominance in addressing this widespread musculoskeletal situation.
Application – Global Viscosupplementation Market breakup from 5 viewpoints:
- Knee
- Hip
- Hand/Wrist
- Ankle/Foot
- Others
The orthopedic clinics and Ambulatory Surgical Centers (ASCs) are witnessing a surge in the viscosupplementation market.
As healthcare traits shift toward cost-effective and patient-centric solutions, those centers offer faster, more reachable viscosupplementation processes, lowering the need for hospitalization. The outpatient placement aligns with the desire for minimally invasive interventions, providing a handy alternative for healthcare providers and patients. The growing popularity of orthopedic clinics and ASCs underscores the developing demand for streamlined, efficient care delivery models, contributing substantially to the increasing panorama of viscosupplementation in the medical field.
End User – Global Viscosupplementation Market breakup from 2 viewpoints:
- Hospitals
- Orthopedic clinics/Ambulatory Surgical Centers
China is poised to contribute considerably to the viscosupplementation market because of its growing older population and increasing prevalence of osteoarthritis.
With a developing middle class and advanced healthcare infrastructure, there is a rising awareness and demand for advanced orthopedic treatments. The Chinese authorities’ consciousness of healthcare reforms similarly supports market enlargement. Also, adopting Western life contributes to musculoskeletal issues, amplifying the want for viscosupplementation. As China strives for better healthcare accessibility, affordability, and innovation, the combination of demographic factors and evolving healthcare guidelines positions the country as a massive participant in propelling the growth of the viscosupplementation market.
Region – Global Viscosupplementation Market Breakup from 5 viewpoints:
- North America
- United States
- Canada
- Europe
- France
- Germany
- Italy
- Spain
- United Kingdom
- Belgium
- Netherlands
- Turkey
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
- Malaysia
- Indonesia
- New Zealand
- South America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape.
The top players in the global viscosupplementation market are Anika Therapeutics Inc., Zimmer Biomet, Smith & Nephew PLC, F.Hoffmann-La Roche Ltd., Sanofi, Chugai Pharmaceutical Co., Lifecore Biomedical, and LG Life Sciences Ltd.
Company Analysis
Ø Overview
Ø Recent Development
Ø Revenue
Key Players
- Anika Therapeutics Inc
- Zimmer Biomet
- Smith & Nephew PLC
- F.Hoffmann-La Roche Ltd
- Sanofi
- Chugai Pharmaceutical Co
- Lifecore Biomedical
- LG Life Sciences Ltd
